N-[11C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs

被引：0
|
作者：
S. V. Hartimath
M. A. Khayum
A. van Waarde
R. A. J. O. Dierckx
E. F. J. de Vries
机构：
[1] University of Groningen,Department of Nuclear Medicine and Molecular Imaging
[2] University Medical Center Groningen,undefined
来源：
Molecular Imaging and Biology | 2017年 / 19卷
关键词：
Pet; Logan graphical analysis; Compartment modeling; Receptor occupancy; CXCR4 receptors imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：570 / 577
页数：7
相关论文
共 50 条
  • [1] N-[11C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs
    Hartimath, S. V.
    Khayum, M. A.
    van Waarde, A.
    Dierckx, R. A. J. O.
    de Vries, E. F. J.
    MOLECULAR IMAGING AND BIOLOGY, 2017, 19 (04) : 570 - 577
  • [2] N-[11C] methyl-AMD3465 a new tracer for PET imaging of CXCR4 receptors
    Hartimath, S. V.
    Dierckx, R.
    d. Vries, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S198 - S198
  • [3] Evaluation of N-[11C]Methyl-AMD3465 as a PET Tracer for Imaging of CXCR4 Receptor Expression in a C6 Glioma Tumor Model
    Hartimath, S. V.
    van Waarde, A.
    Dierckx, R. A. J. O.
    de Vries, E. F. J.
    MOLECULAR PHARMACEUTICS, 2014, 11 (11) : 3810 - 3817
  • [4] Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[11C]Methyl-AMD3465 PET
    Hartimath, S. V.
    Draghiciu, O.
    Daemen, T.
    Nijman, H. W.
    van Waarde, A.
    Dierckx, R. A. J. O.
    de Vries, E. F. J.
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (04) : 883 - 890
  • [5] Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[11C]Methyl-AMD3465 PET
    SV Hartimath
    O. Draghiciu
    T Daemen
    H.W. Nijman
    A. van Waarde
    R.A.J.O. Dierckx
    E.F.J. de Vries
    Molecular Imaging and Biology, 2020, 22 : 883 - 890
  • [6] Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4
    Bodart, Veronique
    Anastassov, Virginia
    Darkes, Marilyn C.
    Idzan, Stefan R.
    Labrecque, Jean
    Lau, Gloria
    Mosi, Renee M.
    Neff, Kathleen S.
    Nelson, Kim L.
    Ruzek, Melanie C.
    Patel, Ketan
    Santucci, Zefferino
    Scarborough, Robert
    Wong, Rebecca S. Y.
    Bridger, Gary J.
    MacFarland, Ron T.
    Fricker, Simon P.
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (08) : 993 - 1000
  • [7] Characterization and optimization of the radiochemical synthesis of [18F]AMD3465: a potential PET imaging agent for Chemokine Receptor CXCR4
    Nan, Liu
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [8] Blockade of the chemokine receptor CXCR4 with AMD3100 in endotoxemia is associated with deleterious effects in vivo
    Seemann, S.
    Lupp, A.
    INFECTION, 2015, 43 : S8 - S8
  • [9] The chemokine receptor CXCR4 antagonist AMD3100 exerts deleterious effects in endotoxemia in vivo
    Seemann, S.
    Lupp, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S64 - S65
  • [10] In vivo imaging of chemokine receptor CXCR4 expression by PET/MRI in patients with myeloid malignancies
    Herhaus, P.
    Philipp-Abbrederis, K.
    Habringer, S.
    Vag, T.
    Hoellein, A.
    Gerngross, C.
    Mueller-Thomas, C.
    Schwamborn, K.
    Peschel, C.
    Schwaiger, M.
    Wester, H. -J
    Verbeek, M.
    Goetze, K.
    Keller, U.
    Oncology Research and Treatment, 2015, 38 : 215 - 215
12345